Suchbegriffe: PULMONARY ARTERIAL HYPERTENSION, . Treffer: 157
Aktaa, S; Gale, CP; Brida, M; Giannakoulas, G; Kovacs, G; Adir, Y; Benza, RL; Böhm, M; Coats, A; D'Alto, M; Escribano-Subias, P; Ferrari, P; Galiè, N; Gibbs, JSR; Gin-Sing, W; Hoeper, MM; Humbert, M; Lang, IM; Maron, BA; Meszaros, G; Noordegraaf, AV; Price, LC; Pepke-Zaba, J; Rådegran, G; Reis, A; Sitbon, O; Torbicki, A; Ulrich, S; Rosenkranz, S; Delcroix, M
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023;
Doi: 10.1002/ejhf.2830
PubMed
FullText
FullText_MUG
Foris, V; Kovacs, G; Avian, A; Bálint, Z; Douschan, P; Ghanim, B; Klepetko, W; Olschewski, A; Olschewski, H
Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study.
Front Physiol. 2022; 13: 986295
Doi: 10.3389/fphys.2022.986295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richter, MJ; Fortuni, F; Alenezi, F; D'Alto, M; Badagliacca, R; Brunner, NW; van, Dijk, AP; Douschan, P; Gall, H; Ghio, S; Giudice, FL; Grünig, E; Haddad, F; Howard, L; Rajagopal, S; Stens, N; Stolfo, D; Thijssen, DHJ; Vizza, CD; Zamanian, RT; Zhong, L; Seeger, W; Ghofrani, HA; Tello, K
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
J Heart Lung Transplant. 2023; 42(4):433-446
Doi: 10.1016/j.healun.2022.11.007
Web of Science
PubMed
FullText
FullText_MUG
van, der, Have, O; Mead, TJ; Westöö, C; Peruzzi, N; Mutgan, AC; Norvik, C; Bech, M; Struglics, A; Hoetzenecker, K; Brunnström, H; Westergren-Thorsson, G; Kwapiszewska, G; Apte, SS; Tran-Lundmark, K
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension.
Pulm Circ. 2023; 13(1):e12200
Doi: 10.1002/pul2.12200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Crnkovic, S; Valzano, F; Fließer, E; Gindlhuber, J; Thekkekara, Puthenparampil, H; Basil, M; Morley, MP; Katzen, J; Gschwandtner, E; Klepetko, W; Cantu, E; Wolinski, H; Olschewski, H; Lindenmann, J; Zhao, YY; Morrisey, EE; Marsh, LM; Kwapiszewska, G
Single-cell transcriptomics reveals skewed cellular communication and phenotypic shift in pulmonary artery remodeling.
JCI Insight. 2022; 7(20):
Doi: 10.1172/jci.insight.153471
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Harbaum, L; Rhodes, CJ; Wharton, J; Lawrie, A; Karnes, JH; Desai, AA; Nichols, WC; Humbert, M; Montani, D; Girerd, B; Sitbon, O; Boehm, M; Novoyatleva, T; Schermuly, RT; Ghofrani, HA; Toshner, M; Kiely, DG; Howard, LS; Swietlik, EM; Gräf, S; Pietzner, M; Morrell, NW; Wilkins, MR, , U.K., National, Institute, for, Health, Research, BioResource, Rare, Diseases, Consortium, U.K., Pulmonary, Arterial, Hypertension, Cohort, Study, Consortium, and, U.S., Pulmonary, Arterial, Hypertension, Biobank, Consortium
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022; 205(12): 1449-1460.
Doi: 10.1164/rccm.202109-2106OC
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Humbert, M; Kovacs, G; Hoeper, MM; Badagliacca, R; Berger, RMF; Brida, M; Carlsen, J; Coats, AJS; Escribano-Subias, P; Ferrari, P; Ferreira, DS; Ghofrani, HA; Giannakoulas, G; Kiely, DG; Mayer, E; Meszaros, G; Nagavci, B; Olsson, KM; Pepke-Zaba, J; Quint, JK; Rådegran, G; Simonneau, G; Sitbon, O; Tonia, T; Toshner, M; Vachiery, JL; Vonk, Noordegraaf, A; Delcroix, M; Rosenkranz, S, , ESC/ERS, Scientific, Document, Group
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J. 2022; 43(38):3618-3731
Doi: 10.1093/eurheartj/ehac237
Web of Science
PubMed
FullText
FullText_MUG
Kremer, N; Rako, Z; Douschan, P; Gall, H; Ghofrani, HA; Grimminger, F; Guth, S; Naeije, R; Rieth, A; Schulz, R; Seeger, W; Tedford, RJ; Vadász, I; Vanderpool, R; Wiedenroth, CB; Richter, MJ; Tello, K
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension.
J Heart Lung Transplant. 2022; 41(3):345-355
Doi: 10.1016/j.healun.2021.11.019
Web of Science
PubMed
FullText
FullText_MUG
Sinha, M; Zabini, D; Guntur, D; Nagaraj, C; Enyedi, P; Olschewski, H; Kuebler, WM; Olschewski, A
Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosis.
Pharmacol Ther. 2022; 237:108249
Doi: 10.1016/j.pharmthera.2022.108249
Web of Science
PubMed
FullText
FullText_MUG
Veith, C; Vartürk-Özcan, I; Wujak, M; Hadzic, S; Wu, CY; Knoepp, F; Kraut, S; Petrovic, A; Gredic, M; Pak, O; Brosien, M; Heimbrodt, M; Wilhelm, J; Weisel, FC; Malkmus, K; Schäfer, K; Gall, H; Tello, K; Kosanovic, D; Sydykov, A; Sarybaev, A; Günther, A; Brandes, RP; Seeger, W; Grimminger, F; Ghofrani, HA; Schermuly, RT; Kwapiszewska, G; Sommer, N; Weissmann, N
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Circulation. 2022; 145(12):916-933
Doi: 10.1161/CIRCULATIONAHA.121.057001
Web of Science
PubMed
FullText
FullText_MUG
Diekmann, F; Chouvarine, P; Sallmon, H; Meyer-Kobbe, L; Kieslich, M; Plouffe, BD; Murthy, SK; Lichtinghagen, R; Legchenko, E; Hansmann, G
Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
Int J Mol Sci. 2021; 22(16):
Doi: 10.3390/ijms22168591
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fließer, E; Birnhuber, A; Marsh, LM; Gschwandtner, E; Klepetko, W; Olschewski, H; Kwapiszewska, G
Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
J Pathol Clin Res. 2021; 7(5):446-458
Doi: 10.1002/cjp2.224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Foris, V; Kovacs, G; Olschewski, H
Update on pulmonary hypertension focusing on lung diseases
PNEUMOLOGE. 2021; 18(3): 195-206.
Doi: 10.1007/s10405-021-00392-3
Web of Science
FullText
FullText_MUG
Hoeper, MM; Al-Hiti, H; Benza, RL; Chang, SA; Corris, PA; Gibbs, JSR; Grünig, E; Jansa, P; Klinger, JR; Langleben, D; McLaughlin, VV; Meyer, GMB; Ota-Arakaki, J; Peacock, AJ; Pulido, T; Rosenkranz, S; Vizza, CD; Vonk-Noordegraaf, A; White, RJ; Chang, M; Kleinjung, F; Meier, C; Paraschin, K; Ghofrani, HA; Simonneau, G; REPLACE investigators
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Lancet Respir Med. 2021;
Doi: 10.1016/S2213-2600(20)30532-4
Web of Science
PubMed
FullText
FullText_MUG
Jud, P; Meinitzer, A; Strohmaier, H; Schwantzer, G; Foris, V; Kovacs, G; Avian, A; Odler, B; Moazedi-Furst, F; Brodmann, M; Hafner, F
Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosis
CLIN EXP RHEUMATOL. 2021; 39(4): S57-S65.
Web of Science
PubMed
Kovacs, G; Olschewski, H
The definition of pulmonary hypertension: history, practical implications and current controversies
BREATHE. 2021; 17(3): 210076
Doi: 10.1183/20734735.0076-2021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Le, Ribeuz, H; To, L; Ghigna, MR; Martin, C; Nagaraj, C; Dreano, E; Rucker-Martin, C; Girerd, B; Bouligand, J; Pechoux, C; Lambert, M; Boet, A; Issard, J; Mercier, O; Hoetzenecker, K; Manoury, B; Becq, F; Burgel, PR; Cottart, CH; Olschewski, A; Sermet-Gaudelus, I; Perros, F; Humbert, M; Montani, D; Antigny, F
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension.
Eur Respir J. 2021; 58(5):
Doi: 10.1183/13993003.00653-2020
Web of Science
PubMed
FullText
FullText_MUG
Mandras, S; Kovacs, G; Olschewski, H; Broderick, M; Nelsen, A; Shen, E; Champion, H
Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
J Cardiovasc Pharmacol Ther. 2021; 26(5):453-462
Doi: 10.1177/10742484211006531
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Maron, BA; Abman, SH; Elliott, CG; Frantz, RP; Hopper, RK; Horn, EM; Nicolls, MR; Shlobin, OA; Shah, SJ; Kovacs, G; Olschewski, H; Rosenzweig, EB
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
Am J Respir Crit Care Med. 2021; 203(12): 1472-1487.
Doi: 10.1164/rccm.202012-4317SO
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Meinel, K; Koestenberger, M; Sallmon, H; Hansmann, G; Pieles, GE
Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young.
Diagnostics (Basel). 2020; 11(1):
Doi: 10.3390/diagnostics11010049
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Olschewski, H
The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.
DIAGNOSTICS. 2021; 11(2): 311
Doi: 10.3390/diagnostics11020311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hansmann, G; Meinel, K; Bukova, M; Chouvarine, P; Wåhlander, H; Koestenberger, M; European Pediatric Pulmonary Vascular Disease Network (EPPVDN)
Selexipag for the treatment of children with pulmonary arterial hypertension: First multicenter experience in drug safety and efficacy.
J Heart Lung Transplant. 2020; 39(7):695-706
Doi: 10.1016/j.healun.2020.03.029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hasan, B; Hansmann, G; Budts, W; Heath, A; Hoodbhoy, Z; Jing, ZC; Koestenberger, M; Meinel, K; Mocumbi, AO; Radchenko, GD; Sallmon, H; Sliwa, K; Kumar, RK; European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, CSC, PASCAR, PCS, and PCSI
Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020; 75(19):2463-2477
Doi: 10.1016/j.jacc.2020.03.047
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hodgson, J; Swietlik, EM; Salmon, RM; Hadinnapola, C; Nikolic, I; Wharton, J; Guo, J; Liley, J; Haimel, M; Bleda, M; Southgate, L; Machado, RD; Martin, JM; Treacy, CM; Yates, K; Daugherty, LC; Shamardina, O; Whitehorn, D; Holden, S; Bogaard, HJ; Church, C; Coghlan, G; Condliffe, R; Corris, PA; Danesino, C; Eyries, M; Gall, H; Ghio, S; Ghofrani, HA; Gibbs, JSR; Girerd, B; Houweling, AC; Howard, L; Humbert, M; Kiely, DG; Kovacs, G; Lawrie, A; MacKenzie Ross, RV; Moledina, S; Montani, D; Olschewski, A; Olschewski, H; Ouwehand, WH; Peacock, AJ; Pepke-Zaba, J; Prokopenko, I; Rhodes, CJ; Scelsi, L; Seeger, W; Soubrier, F; Suntharalingam, J; Toshner, MR; Trembath, RC; Noordegraaf, AV; Wort, SJ; Wilkins, MR; Yu, PB; Li, W; Gräf, S; Upton, PD; Morrell, NW
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2020; 201(5):575-585
Doi: 10.1164/rccm.201906-1141OC
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Inampudi, C; Tedford, RJ; Hemnes, AR; Hansmann, G; Bogaard, HJ; Koestenberger, M; Lang, IM; Brittain, EL
Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension.
Cardiovasc Diagn Ther. 2020; 10(5):1659-1674
Doi: 10.21037/cdt-20-348
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jandl, K; Marsh, LM; Hoffmann, J; Mutgan, AC; Baum, O; Bloch, W; Thekkekara-Puthenparampil, H; Kolb, D; Sinn, K; Klepetko, W; Heinemann, A; Olschewski, A; Olschewski, H; Kwapiszewska, G
Basement Membrane Remodeling Controls Endothelial Function in Idiopathic Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2020; 63(1):104-117
Doi: 10.1165/rcmb.2019-0303OC
Web of Science
PubMed
FullText
FullText_MUG
Kaemmerer, H; Gorenflo, M; Huscher, D; Pittrow, D; Apitz, C; Baumgartner, H; Berger, F; Bruch, L; Brunnemer, E; Budts, W; Claussen, M; Coghlan, G; Dähnert, I; D'Alto, M; Delcroix, M; Distler, O; Dittrich, S; Dumitrescu, D; Ewert, R; Faehling, M; Germund, I; Ghofrani, HA; Grohé, C; Grossekreymborg, K; Halank, M; Hansmann, G; Harzheim, D; Nemes, A; Havasi, K; Held, M; Hoeper, MM; Hofbeck, M; Hohenfrost-Schmidt, W; Jurevičienė, E; Gumbienè, L; Kabitz, HJ; Klose, H; Köhler, T; Konstantinides, S; Köestenberger, M; Kozlik-Feldmann, R; Kramer, HH; Kropf-Sanchen, C; Lammers, A; Lange, T; Meyn, P; Miera, O; Milger-Kneidinger, K; Neidenbach, R; Neurohr, C; Opitz, C; Perings, C; Remppis, BA; Riemekasten, G; Scelsi, L; Scholtz, W; Simkova, I; Skowasch, D; Skride, A; Stähler, G; Stiller, B; Tsangaris, I; Vizza, CD; Vonk Noordegraaf, A; Wilkens, H; Wirtz, H; Diller, GP; Grünig, E; Rosenkranz, S
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
J Clin Med. 2020; 9(5):
Doi: 10.3390/jcm9051456
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mutgan, AC; Jandl, K; Kwapiszewska, G
Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?
Cells. 2020; 9(9):
Doi: 10.3390/cells9092029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ramjug, S; Weatherald, J; Sahay, S; Khoury, J; Foris, V; Chandran, N; Bokan, A; Godinas, L; Delcroix, M
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly.
ERJ Open Res. 2020; 6(4):
Doi: 10.1183/23120541.00304-2020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schweintzger, S; Koestenberger, M; Schlagenhauf, A; Grangl, G; Burmas, A; Kurath-Koller, S; Pocivalnik, M; Sallmon, H; Baumgartner, D; Hansmann, G; Gamillscheg, A
Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertension.
Cardiovasc Diagn Ther. 2020; 10(5):1675-1685
Doi: 10.21037/cdt.2020.04.01
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Skofic Maurer, D; Zabini, D; Nagaraj, C; Sharma, N; Lengyel, M; Nagy, BM; Frank, S; Klepetko, W; Gschwandtner, E; Enyedi, P; Kwapiszewska, G; Olschewski, H; Olschewski, A
Endothelial Dysfunction Following Enhanced TMEM16A Activity in Human Pulmonary Arteries.
Cells. 2020; 9(9):
Doi: 10.3390/cells9091984
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Swietlik, EM; Greene, D; Zhu, N; Megy, K; Cogliano, M; Rajaram, S; Pandya, D; Tilly, T; Lutz, KA; Welch, CCL; Pauciulo, MW; Southgate, L; Martin, JM; Treacy, CM; Penkett, CJ; Stephens, JC; Bogaard, HJ; Church, C; Coghlan, G; Coleman, AW; Condliffe, R; Eichstaedt, CA; Eyries, M; Gall, H; Ghio, S; Girerd, B; Grünig, E; Holden, S; Howard, L; Humbert, M; Kiely, DG; Kovacs, G; Lordan, J; Machado, RD; Mackenzie, Ross, RV; McCabe, C; Moledina, S; Montani, D; Olschewski, H; Pepke-Zaba, J; Price, L; Rhodes, CJ; Seeger, W; Soubrier, F; Suntharalingam, J; Toshner, MR; Vonk, Noordegraaf, A; Wharton, J; Wild, JM; Wort, SJ; Lawrie, A; Wilkins, MR; Trembath, RC; Shen, Y; Chung, WK; Swift, AJ; Nichols, WC; Morrell, NW; Gräf, S
Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.
Circ Genom Precis Med. 2020; 14(1):e003155
Doi: 10.1161/CIRCGEN.120.003155
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Crnkovic, S; Egemnazarov, B; Damico, R; Marsh, LM; Nagy, BM; Douschan, P; Atsina, K; Kolb, TM; Mathai, SC; Hooper, JE; Ghanim, B; Klepetko, W; Fruhwald, F; Lassner, D; Olschewski, A; Olschewski, H; Hassoun, PM; Kwapiszewska, G
Disconnect between Fibrotic Response and Right Ventricular Dysfunction.
Am J Respir Crit Care Med. 2019; 199(12):1550-1560
Doi: 10.1164/rccm.201809-1737OC
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Foris, V; Brcic, L; Douschan, P; Kovacs, G; Stacher-Priehse, E; Olschewski, H
Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT.
Pulm Circ. 2019; 9(3): 2045894019832214
Doi: 10.1177/2045894019832214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Humbert, M; Guignabert, C; Bonnet, S; Dorfmüller, P; Klinger, JR; Nicolls, MR; Olschewski, AJ; Pullamsetti, SS; Schermuly, RT; Stenmark, KR; Rabinovitch, M
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
Eur Respir J. 2019; 53(1):
Doi: 10.1183/13993003.01887-2018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jandl, K; Thekkekara Puthenparampil, H; Marsh, LM; Hoffmann, J; Wilhelm, J; Veith, C; Sinn, K; Klepetko, W; Olschewski, H; Olschewski, A; Brock, M; Kwapiszewska, G
Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1.
J Pathol. 2019; 247(3):357-370
Doi: 10.1002/path.5195
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koestenberger, M; Sallmon, H; Hansmann, G; European Pediatric Pulmonary Vascular Disease Network
A pediatric perspective on the TAPSE/PASP ratio in pulmonary arterial hypertension.
INT J CARDIOL. 2019; 278: 242-242.
Doi: 10.1016/j.ijcard.2018.11.092
Web of Science
PubMed
FullText
FullText_MUG
Kwapiszewska, G; Johansen, AKZ; Gomez-Arroyo, J; Voelkel, NF
Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases.
Circ Res. 2019; 125(3):356-366
Doi: 10.1161/CIRCRESAHA.119.315054
Web of Science
PubMed
FullText
FullText_MUG
Papp, R; Nagaraj, C; Zabini, D; Nagy, BM; Lengyel, M; Skofic Maurer, D; Sharma, N; Egemnazarov, B; Kovacs, G; Kwapiszewska, G; Marsh, LM; Hrzenjak, A; Höfler, G; Didiasova, M; Wygrecka, M; Sievers, LK; Szucs, P; Enyedi, P; Ghanim, B; Klepetko, W; Olschewski, H; Olschewski, A
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.
Eur Respir J. 2019; 53(6): 1800965
Doi: 10.1183/13993003.00965-2018
Web of Science
PubMed
FullText
FullText_MUG
Rhodes, CJ; Batai, K; Bleda, M; Haimel, M; Southgate, L; Germain, M; Pauciulo, MW; Hadinnapola, C; Aman, J; Girerd, B; Arora, A; Knight, J; Hanscombe, KB; Karnes, JH; Kaakinen, M; Gall, H; Ulrich, A; Harbaum, L; Cebola, I; Ferrer, J; Lutz, K; Swietlik, EM; Ahmad, F; Amouyel, P; Archer, SL; Argula, R; Austin, ED; Badesch, D; Bakshi, S; Barnett, C; Benza, R; Bhatt, N; Bogaard, HJ; Burger, CD; Chakinala, M; Church, C; Coghlan, JG; Condliffe, R; Corris, PA; Danesino, C; Debette, S; Elliott, CG; Elwing, J; Eyries, M; Fortin, T; Franke, A; Frantz, RP; Frost, A; Garcia, JGN; Ghio, S; Ghofrani, HA; Gibbs, JSR; Harley, J; He, H; Hill, NS; Hirsch, R; Houweling, AC; Howard, LS; Ivy, D; Kiely, DG; Klinger, J; Kovacs, G; Lahm, T; Laudes, M; Machado, RD; MacKenzie Ross, RV; Marsolo, K; Martin, LJ; Moledina, S; Montani, D; Nathan, SD; Newnham, M; Olschewski, A; Olschewski, H; Oudiz, RJ; Ouwehand, WH; Peacock, AJ; Pepke-Zaba, J; Rehman, Z; Robbins, I; Roden, DM; Rosenzweig, EB; Saydain, G; Scelsi, L; Schilz, R; Seeger, W; Shaffer, CM; Simms, RW; Simon, M; Sitbon, O; Suntharalingam, J; Tang, H; Tchourbanov, AY; Thenappan, T; Torres, F; Toshner, MR; Treacy, CM; Vonk Noordegraaf, A; Waisfisz, Q; Walsworth, AK; Walter, RE; Wharton, J; White, RJ; Wilt, J; Wort, SJ; Yung, D; Lawrie, A; Humbert, M; Soubrier, F; Trégouët, DA; Prokopenko, I; Kittles, R; Gräf, S; Nichols, WC; Trembath, RC; Desai, AA; Morrell, NW; Wilkins, MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.
Lancet Respir Med. 2019; 7(3):227-238
Doi: 10.1016/S2213-2600(18)30409-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rosenkranz, S; Diller, GP; Dumitrescu, D; Ewert, R; Ghofrani, HA; Grünig, E; Halank, M; Held, M; Kaemmerer, H; Klose, H; Kovacs, G; Konstantinides, S; Lang, IM; Lange, TJ; Leuchte, H; Mayer, E; Olschewski, A; Olschewski, H; Olsson, KM; Opitz, C; Schermuly, RT; Seeger, W; Wilkens, H; Hoeper, MM
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].
Dtsch Med Wochenschr. 2019; 144(19):1367-1372
Doi: 10.1055/a-0918-3772
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Spiekerkoetter, E; Goncharova, EA; Guignabert, C; Stenmark, K; Kwapiszewska, G; Rabinovitch, M; Voelkel, N; Bogaard, HJ; Graham, B; Pullamsetti, SS; Kuebler, WM
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.
Pulm Circ. 2019; 9(4): 2045894019889775-2045894019889775.
Doi: 10.1177/2045894019889775
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zucker, MM; Wujak, L; Gungl, A; Didiasova, M; Kosanovic, D; Petrovic, A; Klepetko, W; Schermuly, RT; Kwapiszewska, G; Schaefer, L; Wygrecka, M
LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1604-1616
Doi: 10.1016/j.bbadis.2019.03.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Biasin, V; Wygrecka, M; Bärnthaler, T; Jandl, K; Jain, PP; Bálint, Z; Kovacs, G; Leitinger, G; Kolb-Lenz, D; Kornmueller, K; Peters, F; Sinn, K; Klepetko, W; Heinemann, A; Olschewski, A; Becker-Pauly, C; Kwapiszewska, G
Docking of Meprin α to Heparan Sulphate Protects the Endothelium from Inflammatory Cell Extravasation.
Thromb Haemost. 2018; 118(10):1790-1802
Doi: 10.1055/s-0038-1670657
Web of Science
PubMed
FullText
FullText_MUG
Crnkovic, S; Marsh, LM; El Agha, E; Voswinckel, R; Ghanim, B; Klepetko, W; Stacher-Priehse, E; Olschewski, H; Bloch, W; Bellusci, S; Olschewski, A; Kwapiszewska, G
Resident cell lineages are preserved in pulmonary vascular remodeling.
J Pathol. 2018; 244(4):485-498
Doi: 10.1002/path.5044
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Douschan, P; Kovacs, G; Foris, V; Kuehnelt-Leddihn, M; Olschewski, H
Imatinib for right heart failure in COPD.
Pulm Circ. 2018; 9(1):2045894018816974-2045894018816974
Doi: 10.1177/2045894018816974
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fazakas, C; Nagaraj, C; Zabini, D; Végh, AG; Marsh, LM; Wilhelm, I; Krizbai, IA; Olschewski, H; Olschewski, A; Bálint, Z
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension.
Front Physiol. 2018; 9:537-537
Doi: 10.3389/fphys.2018.00537
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gräf, S; Haimel, M; Bleda, M; Hadinnapola, C; Southgate, L; Li, W; Hodgson, J; Liu, B; Salmon, RM; Southwood, M; Machado, RD; Martin, JM; Treacy, CM; Yates, K; Daugherty, LC; Shamardina, O; Whitehorn, D; Holden, S; Aldred, M; Bogaard, HJ; Church, C; Coghlan, G; Condliffe, R; Corris, PA; Danesino, C; Eyries, M; Gall, H; Ghio, S; Ghofrani, HA; Gibbs, JSR; Girerd, B; Houweling, AC; Howard, L; Humbert, M; Kiely, DG; Kovacs, G; MacKenzie Ross, RV; Moledina, S; Montani, D; Newnham, M; Olschewski, A; Olschewski, H; Peacock, AJ; Pepke-Zaba, J; Prokopenko, I; Rhodes, CJ; Scelsi, L; Seeger, W; Soubrier, F; Stein, DF; Suntharalingam, J; Swietlik, EM; Toshner, MR; van Heel, DA; Vonk Noordegraaf, A; Waisfisz, Q; Wharton, J; Wort, SJ; Ouwehand, WH; Soranzo, N; Lawrie, A; Upton, PD; Wilkins, MR; Trembath, RC; Morrell, NW
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.
Nat Commun. 2018; 9(1): 1416-1416.
Doi: 10.1038/s41467-018-03672-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koestenberger, M; Avian, A; Gamillscheg, A; Sallmon, H; Grangl, G; Burmas, A; Schweintzger, S; Kurath-Koller, S; Cvirn, G; Hansmann, G
Right ventricular base/apex ratio in the assessment of pediatric pulmonary arterial hypertension: Results from the European Pediatric Pulmonary Vascular Disease Network.
Clin Cardiol. 2018; 41(9):1144-1149
Doi: 10.1002/clc.22994
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koestenberger, M; Hansmann, G
Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
Pulm Circ. 2018; 8(3):2045894018793580-2045894018793580
Doi: 10.1177/2045894018793580
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen